glp 1 agonist new Curious about the latest in weight management and diabetes treatment? Learn about GLP-1/GIP dual agonists. We're enrolling patients for a research study testing this treatment! Want to see if you qualify? GLP-1 Agonists Weight Loss Drugs
Description
First, we consider findings from post-marketing reports, which represent analyses of data reported to Food and Drug Administration (FDA) by prescribers and/or patients
Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity
Saxenda's unique characteristics and star power make it a valuable member of the weight management ensemble
During hypoglycaemia, insulin secretion is reduced and glucagon secretion is not inhibited
Figlioli G., et al
doi:10.1210/en.2011-1502 127
